Literature DB >> 3889837

Efficient secretion and purification of human insulin-like growth factor I with a gene fusion vector in Staphylococci.

B Nilsson, E Holmgren, S Josephson, S Gatenbeck, L Philipson, M Uhlen.   

Abstract

A novel approach for production of small polypeptides, using a staphylococcal protein A vector, is described. This system is used to express, secrete and purify human insulin-like growth factor I (IGF-I). A fusion protein consisting of protein A and IGF-I is recovered in high yield by passing the culture medium through an IgG affinity column. Using site-specific mutagenesis an acid labile asp-pro cleavage site was introduced at the fusion point between the two proteins. The protein A "tail" can thereby be removed from the affinity purified fusion protein by chemical cleavage releasing biologically active IGF-I molecules.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3889837      PMCID: PMC341062          DOI: 10.1093/nar/13.4.1151

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  20 in total

1.  Cleavage at aspartyl-prolyl bonds.

Authors: 
Journal:  Methods Enzymol       Date:  1977       Impact factor: 1.600

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Rapid purification of a cloned gene product by genetic fusion and site-specific proteolysis.

Authors:  J Germino; D Bastia
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

4.  Expression in Escherichia coli of chemically synthesized genes for human insulin.

Authors:  D V Goeddel; D G Kleid; F Bolivar; H L Heyneker; D G Yansura; R Crea; T Hirose; A Kraszewski; K Itakura; A D Riggs
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

5.  Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum.

Authors:  J Zapf; E Schoenle; E R Froesch
Journal:  Eur J Biochem       Date:  1978-06-15

6.  Effects of streptomycin and novobiocin on Staphylococcus aureus gene expression.

Authors:  K Nordström; M Lindberg
Journal:  J Bacteriol       Date:  1978-02       Impact factor: 3.490

7.  Somatomedin-C and platelet-derived growth factor stimulate human fibroblast replication.

Authors:  D R Clemmons; J J Van Wyk
Journal:  J Cell Physiol       Date:  1981-03       Impact factor: 6.384

8.  Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin.

Authors:  K Itakura; T Hirose; R Crea; A D Riggs; H L Heyneker; F Bolivar; H W Boyer
Journal:  Science       Date:  1977-12-09       Impact factor: 47.728

9.  The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin.

Authors:  E Rinderknecht; R E Humbel
Journal:  J Biol Chem       Date:  1978-04-25       Impact factor: 5.157

10.  Site-specific mutagenesis using oligodeoxyribonucleotides: isolation of a phenotypically silent phi X174 mutant, with a specific nucleotide deletion, at very high efficiency.

Authors:  S Gillam; C R Astell; M Smith
Journal:  Gene       Date:  1980-12       Impact factor: 3.688

View more
  13 in total

1.  Gene synthesis, expression, and mutagenesis of the blue copper proteins azurin and plastocyanin.

Authors:  T K Chang; S A Iverson; C G Rodrigues; C N Kiser; A Y Lew; J P Germanas; J H Richards
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

2.  Enzyme-linked immunosorbent assay for Escherichia coli heat-stable enterotoxin type II.

Authors:  C Handl; B Rönnberg; B Nilsson; E Olsson; H Jonsson; J I Flock
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

3.  Secretion of human serum albumin from Bacillus subtilis.

Authors:  C W Saunders; B J Schmidt; R L Mallonee; M S Guyer
Journal:  J Bacteriol       Date:  1987-07       Impact factor: 3.490

4.  Expression of a synthetic gene encoding human insulin-like growth factor I in cultured mouse fibroblasts.

Authors:  M L Bayne; M A Cascieri; B Kelder; J Applebaum; G Chicchi; J A Shapiro; F Pasleau; J J Kopchick
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  Secretion of heterologous gene products to the culture medium of Escherichia coli.

Authors:  L Abrahmsén; T Moks; B Nilsson; M Uhlén
Journal:  Nucleic Acids Res       Date:  1986-09-25       Impact factor: 16.971

6.  Cloning, sequencing and expression of subtilisin Carlsberg from Bacillus licheniformis.

Authors:  M Jacobs; M Eliasson; M Uhlén; J I Flock
Journal:  Nucleic Acids Res       Date:  1985-12-20       Impact factor: 16.971

7.  Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites.

Authors:  H Tamura; C Kohchi; R Yamada; T Ikeda; O Koiwai; E Patterson; J D Keene; K Okada; E Kjeldsen; K Nishikawa
Journal:  Nucleic Acids Res       Date:  1991-01-11       Impact factor: 16.971

8.  Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide.

Authors:  V L Motin; R Nakajima; G B Smirnov; R R Brubaker
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

9.  Fibroblast adhesion to recombinant tropoelastin expressed as a protein A-fusion protein.

Authors:  L E Grosso; W C Parks; L J Wu; R P Mecham
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

10.  Production of specific antibodies against protein A fusion proteins.

Authors:  B Löwenadler; B Nilsson; L Abrahmsén; T Moks; L Ljungqvist; E Holmgren; S Paleus; S Josephson; L Philipson; M Uhlén
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.